Maurer, M. S., Witteles, R. M., Garcia-Pavia, P., Sheikh, F. H., Morbach, C., Rodriguez Duque, D., Aldinc, E., Eraly, S. A., & Gillmore, J. D. (2025). Impact of Heart Failure Severity on Vutrisiran Efficacy in Transthyretin Amyloidosis with Cardiomyopathy. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2025.03.477

Judge, D. P., Alexander, K. M., Cappelli, F., Fontana, M., Garcia-Pavia, P., Gibbs, S. D. J., Grogan, M., Hanna, M., Masri, A., Maurer, M. S., Obici, L., Soman, P., Cao, X., Lystig, T., Tamby, J.-F., Siddhanti, S., Castaño, A., Katz, L., Fox, J. C., … Gillmore, J. D. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology, 85(10), 1003–1014. https://doi.org/10.1016/j.jacc.2024.11.042

Hsu, S. Y., Kuo, E. J., McManus, C., Liou, R., Lee, J. A., & Kuo, J. H. (2025). Utility of Parathyroid Autofluorescence in Differentiating Parathyroid Pathology. World Journal of Surgery. Portico. https://doi.org/10.1002/wjs.12524

Song, A., Mellgard, G., Bellofiore, C., Basset, M., Nuvolone, M., Foli, A., Merlini, G., Maurer, M. S., Mapara, M. Y., Bhutani, D., Lentzsch, S., Shaish, H., Palladini, G., Chakraborty, R., & Milani, P. (2025). Diffuse Lung Involvement as a Rare Presentation of Systemic AL Amyloidosis: A Retrospective Cohort Study. Blood Advances. https://doi.org/10.1182/bloodadvances.2024015646

Henner, D. E., Drambarean, B., Gerbeling, T. M., Kendrick, J. B., Kendrick, W. T., Koester-Wiedemann, L., Nickolas, T. L., Rastogi, A., Rauf, A. A., Dyson, B., Singer, M. C., Desai, P., Fox, K. M., Cheng, S., & Goodman, W. (2025). Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel. PLOS ONE, 20(1), e0266281. https://doi.org/10.1371/journal.pone.0266281

Lyons, G., Thompson, J., Lousada, I., Catini, J., Manwani, R., & Maurer, M. S. (2025). Diagnostic pathways, cardiac manifestations and outcomes in light chain amyloidosis: analysis of a US claims database. Open Heart, 12(1), e003124. https://doi.org/10.1136/openhrt-2024-003124

Fontana, M., Maurer, M. S., Gillmore, J. D., Bender, S., Jay, P. Y., & Solomon, S. D. (2025). Worsening of Heart Failure in Outpatients With Transthyretin Amyloidosis and Cardiomyopathy in the APOLLO-B Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.10.097

Castellano, T., Wang, T. C., Nolan, E., Archer, D. B., Cody, K., Harrison, T. M., Wu, Y., Durant, A., Janve, V. A., Engelman, C. D., Jagust, W. J., Albert, M. S., Johnson, S. C., Resnick, S. M., Sperling, R. A., Bilgel, M., Saykin, A. J., Vardarajan, B. N., Mayeux, R., … Koran, M. E. I. (2024). Genetic and Sex Associations with Earlier Estimated Onset of Amyloid Positivity from over 4000 Harmonized Positron Emission Tomography Images. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.092852

Folkvaljon, F., Gertz, M., Gillmore, J. D., Khella, S., Masri, A., Maurer, M. S., Cruz, M. W., Wixner, J., Chen, J., Reicher, B., Kwoh, J., Yarlas, A., & Berk, J. L. (2024). Estimating Meaningful Differences in Measures of Neuropathic Impairment, Health‐Related Quality of Life, and Nutritional Status in Patients With Hereditary Transthyretin Amyloidosis. Muscle & Nerve, 71(1), 96–107. Portico. https://doi.org/10.1002/mus.28299

Fontana, M., Maurer, M. S., Gillmore, J. D., Bender, S., Aldinc, E., Eraly, S. A., Jay, P. Y., & Solomon, S. D. (2024). Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.11.015

Tian, L., Jaeger, B. C., Scialla, J. J., Budoff, M. J., Mehta, R. C., Jaar, B. G., Saab, G., Dobre, M. A., Reilly, M. P., Rader, D. J., Townsend, R. R., Lash, J. P., Greenland, P., Isakova, T., Bundy, J. D., Anderson, A. H., Appel, L. J., Chen, J., Cohen, D., … Unruh, M. L. (2024). Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2024.06.018

Bruce, S. L., Cuomo, M., Yarmohammadi, H., Wan, E. Y., Saluja, D., Sciacca, R., Garan, H., Griffin, J. M., Maurer, M. S., & Biviano, A. B. (2024). Monitoring for arrhythmia in transthyretin cardiac amyloidosis with noninvasive ambulatory patch devices. Heart Rhythm O2. https://doi.org/10.1016/j.hroo.2024.07.013

Wardhere, A., Mohamoud, A., Bampatsias, D., & Nor, M. (2024). A-74 | Effect of Cardiac Amyloidosis on Outcomes in Patients Hospitalized for STEMI. Journal of the Society for Cardiovascular Angiography & Interventions, 3(5), 101550. https://doi.org/10.1016/j.jscai.2024.101550

Rubin, M. R., Cusano, N., Yin, S., Tokareva, E., Ayodele, O., & Finkelman, R. D. (2024). Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic Hypoparathyroidism. Endocrine Practice, 30(3), 200–208. https://doi.org/10.1016/j.eprac.2023.12.001

Muchtar, E., Palladini, G., Schonland, S., Dispenzieri, A., Wisniowski, B., Merlini, G., Milani, P., Hegenbart, U., Dittrich, T., Kastritis, E., Dimopoulos, M. A., Sanchorawala, V., Szalat, R. E., Liedtke, M., Gupta, M., Landau, H., Lentzsch, S., Hughes, M. S., Cibeira López, M. T., … Gertz, M. A. (2023). Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study. Blood, 142(Supplement 1), 3411–3411. https://doi.org/10.1182/blood-2023-190226

Wuni, G., Teruya, S., Ionescu, N., Janvier, I., Helmke, S., Fine, D., Ruberg, F., Raiszadeh, F., Kurian, D., Maurer, M., & Vaishnava, P. (2023). Prevalence, adequacy and adherence of anticoagulation for stroke thromboprophylaxis in minority patients with atrial fib referred for transthyretin cardiac amyloidosis screening: The SCAN-MP Study. European Heart Journal, 44(Supplement_2). https://doi.org/10.1093/eurheartj/ehad655.2092

Gordon, E. R., Trager, M. H., Adeuyan, O., Schreidah, C. M., Fahmy, L. M., Lapolla, B. A., Husain, S., Coromilas, A. J., & Geskin, L. J. (2023). Alone on a collagen island: Unique findings of osseous sclerotic bodies in nephrogenic systemic fibrosis. JAAD Case Reports, 40, 117–119. https://doi.org/10.1016/j.jdcr.2023.08.010

Martinez-Calle, M., Courbon, G., Hunt-Tobey, B., Francis, C., Spindler, J., Wang, X., dos Reis, L. M., Martins, C. S. W., Salusky, I. B., Malluche, H., Nickolas, T. L., Moyses, R. M. A., Martin, A., & David, V. (2023). Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy. Journal of Clinical Investigation, 133(11). https://doi.org/10.1172/jci159928

Chan, N., Teruya, S. L., Mirabal, A., Santos, J. D. L., Guadalupe, S., Rodriguez, C., Helmke, S., Cuomo, M., Smiley, D., & Maurer, M. S. (2023). OUTCOMES OF PATIENTS DIAGNOSED WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS: ENDOMYOCARDIAL BIOPSY VERSUS NUCLEAR SCINTIGRAPHY. Journal of the American College of Cardiology, 81(8), 543. https://doi.org/10.1016/s0735-1097(23)00987-7

Rosenblum, H., Gundapaneni, B., Lopez-Charneco, M., Sultan, M., Burkhoff, D., & Maurer, M. S. (2023). TAFAMIDIS DELAYS PROGRESSION OF CARDIAC DYSFUNCTION IN PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS: NON-INVASIVE PRESSURE VOLUME ANALYSIS OF THE ATTR-ACT TRIAL. Journal of the American College of Cardiology, 81(8), 341. https://doi.org/10.1016/s0735-1097(23)00785-4

Chung, A., Driggin, E., Clerkin, K. J., Teruya, S. L., Santos, J. D. L., & Maurer, M. S. (2023). VARIABILITY IN ESTIMATED GLOMERULAR FILTRATION RATE WITH CYSTATIN C VS CREATININE IN PATIENTS WITH TRANSTHYRETIN CARDIAC AMYLOIDOSIS (ATTR-CA). Journal of the American College of Cardiology, 81(8), 619. https://doi.org/10.1016/s0735-1097(23)01063-x

Garcia Pavia, P., Gillmore, J. D., Kale, P., Berk, J. L., Maurer, M. S., Conceição, I., Dicarli, M., Solomon, S., Chen, C., Arum, S., Vest, J., Grogan, M., & Hababou, C. (2023). HELIOS-A: 18-month exploratory cardiac results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis. Archives of Cardiovascular Diseases Supplements, 15(1), 31–32. https://doi.org/10.1016/j.acvdsp.2022.10.056

Cuddy, S. A., Datar, Y., Ovsak, G., Saith, S., Murphy, S. P., Bay, C. P., Haddad, M., Lilleness, B., Muralidhar, V., Pipilas, A., Vuong, J., Guardino, E., Maurer, M. S., Ruberg, F. L., Falk, R. H., & Dorbala, S. (2022). Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis. Circulation: Cardiovascular Imaging, 15(11). https://doi.org/10.1161/circimaging.122.014645

Gonzalez-Lopez, E., Escobar-Lopez, L., Obici, L., Saturi, G., Bezard, M., Saith, S. E., AbouEzzeddine, O. F., Mussinelli, R., Gagliardi, C., Kharoubi, M., Griffin, J. M., Dispenzieri, A., Vilches, S., Perlini, S., Longhi, S., Oghina, S., Rivas, A., Grogan, M., Maurer, M. S., … Garcia-Pavia, P. (2022). Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC: CardioOncology, 4(4), 442–454. https://doi.org/10.1016/j.jaccao.2022.07.007

Rosanoff, A., West, C., Elin, R. J., Micke, O., Baniasadi, S., Barbagallo, M., Campbell, E., Cheng, F.-C., Costello, R. B., Gamboa-Gomez, C., Guerrero-Romero, F., Gletsu-Miller, N., von Ehrlich, B., Iotti, S., Kahe, K., Kim, D. J., Kisters, K., Kolisek, M., … Kraus, A. (2022). Recommendation on an updated standardization of serum magnesium reference ranges. European Journal of Nutrition, 61(7), 3697–3706. https://doi.org/10.1007/s00394-022-02916-w

Westin, O. M., Butt, J. H., Gustafsson, F., Køber, L., Vinther, M., Maurer, M. S., & Fosbøl, E. L. (2022). Carpal Tunnel Syndrome in Patients Who Underwent Pacemaker Implantation and Relation to Amyloidosis, Heart Failure, and Mortality. The American Journal of Cardiology, 177, 121–127. https://doi.org/10.1016/j.amjcard.2022.04.059

Vilches, S., Fontana, M., Gonzalez‐Lopez, E., Mitrani, L., Saturi, G., Renju, M., Griffin, J. M., Caponetti, A., Gnanasampanthan, S., De los Santos, J., Gagliardi, C., Rivas, A., Dominguez, F., Longhi, S., Rapezzi, C., Maurer, M. S., Gillmore, J., & Garcia‐Pavia, P. (2022). Systemic embolism in amyloid transthyretin cardiomyopathy. European Journal of Heart Failure, 24(8), 1387–1396. Portico. https://doi.org/10.1002/ejhf.2566

Cuddy, S. A. M., Jerosch-Herold, M., Falk, R. H., Kijewski, M. F., Singh, V., Ruberg, F. L., Sanchorawala, V., Landau, H., Maurer, M. S., Yee, A. J., Bianchi, G., Di Carli, M. F., Liao, R., Kwong, R. Y., & Dorbala, S. (2022). Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy. JACC: Cardiovascular Imaging, 15(4), 594–603. https://doi.org/10.1016/j.jcmg.2021.09.032

Bhogal, S., Garcia-Garcia, H. M., Klein, A., Benzuly, K., Mangalmurti, S., Moses, J., Alaswad, K., Jaffer, F., Yong, C., Nanjundappa, A., Ben-Dor, I., Mintz, G. S., Hashim, H., & Waksman, R. (2022). CRT-100.04 Intravascular Lithotripsy for the Treatment of Severely Calcified Coronary Artery Disease: An IVUS Sub-Study. JACC: Cardiovascular Interventions, 15(4), S1. https://doi.org/10.1016/j.jcin.2022.01.073